New malaria vaccine shows promiseBMJ 1999; 318 doi: https://doi.org/10.1136/bmj.318.7183.557 (Published 27 February 1999) Cite this as: BMJ 1999;318:557
- Deborah Josefson,
- San Francisco
An experimental malaria vaccine designed to protect the host from each stage of the parasite's life cycle has shown promise in animal trials (Proceedings of the National Academy of Sciences 1999;96:1615-20).
Researchers from the US Centers for Disease Control and Prevention in Atlanta, Georgia, have created a recombinant, multivalent vaccine against Plasmodium falciparum, the deadliest malaria parasite. This vaccine differs from previous vaccines because it …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial